Updated: January 14, 2026
How to Help Your Patients Save Money on Norgesic: A Provider's Guide to Savings Programs
Author
Peter Daggett

Summarize with AI
- The Pricing Problem: Why Sticker Shock Kills Prescription Adherence
- Primary Savings Option: Galt Pharmaceuticals Patient Assistance Program (PAP)
- Tier 1: Commercially Insured Patients — Copay Assistance Card
- Tier 2: Uninsured or Underinsured Patients — Cash-Pay Option
- Integrating the PAP into Your Practice Workflow
- Savings Options for Medicare and Medicaid Patients
- Using medfinder to Support Patient Access
- Quick Reference: Norgesic Savings Summary for Providers
Norgesic's retail price can exceed $1,400 per fill — but Galt's PAP makes it $0 for most commercially insured patients. Here's what providers need to know about savings programs.
For providers who prescribe Norgesic (orphenadrine/aspirin/caffeine), patient cost is one of the primary barriers to a successful fill. The retail list price for brand-name Norgesic can exceed $1,400 per 60-tablet supply — a price that causes immediate prescription abandonment without the right savings program in place. The good news: Galt Pharmaceuticals has built a comprehensive Patient Assistance Program that makes Norgesic genuinely affordable for most commercially insured and uninsured patients. This guide walks you through every available savings mechanism and how to integrate it into your prescribing workflow.
The Pricing Problem: Why Sticker Shock Kills Prescription Adherence
Prescription abandonment at the pharmacy counter is a well-documented phenomenon. Studies consistently show that patients are significantly more likely to abandon prescriptions when the out-of-pocket cost exceeds $100. For Norgesic, the retail cash price without any assistance program can be $1,400 or more for a 60-tablet supply — an amount that would cause the vast majority of patients to leave empty-handed.
This creates a clinical problem: you've made an appropriate prescribing decision, but the patient never takes the medication because of the price. Understanding the savings ecosystem for Norgesic and communicating it to patients at the point of care is essential for achieving therapeutic outcomes.
Primary Savings Option: Galt Pharmaceuticals Patient Assistance Program (PAP)
Galt Pharmaceuticals offers a robust Patient Assistance Program specifically designed to make Norgesic accessible. The program operates through a dedicated dispensing pharmacy model (Sterling Specialty Pharmacy / Galt Central Fulfillment Pharmacy) and provides two tiers of savings:
Tier 1: Commercially Insured Patients — Copay Assistance Card
Eligible commercially insured patients (18+) can use Galt's copay assistance card at the dispensing pharmacy, which covers up to $150 per prescription. In most cases, this means patients pay $0 out-of-pocket per fill. The card is available for download at norgesic.com/resources.
Key details for patient enrollment:
Patient must be 18 years or older
Prescription must be for brand-name Norgesic (not the generic)
Must be filled at Galt's designated dispensing pharmacy
NOT valid for prescriptions covered by Medicare, Medicaid, TRICARE, or other federal/state programs
Eligibility restrictions apply — check norgesic.com for current terms
Tier 2: Uninsured or Underinsured Patients — Cash-Pay Option
For patients who are uninsured, underinsured, or whose insurance does not cover Norgesic, Galt offers a cash-pay option through the Galt Central Fulfillment Pharmacy:
$30 for 60 tablets (standard supply)
$45 for 90 tablets (extended supply)
Maximum $60 regardless of quantity, including home delivery
This is a substantial value proposition for uninsured patients and represents one of the lowest per-tablet costs available for a branded muscle relaxant combination product.
Integrating the PAP into Your Practice Workflow
The PAP only works if patients know about it at the time of the visit — not after they've already abandoned the prescription at the pharmacy. Here's how to build it in:
Register with Galt: Visit norgesic.com and download the provider resources package. This includes the patient copay card, prescriber information sheet, and Sterling Specialty Pharmacy routing information.
Keep copay cards stocked in exam rooms: Hand the appropriate card to every patient receiving a Norgesic prescription before they leave. One card for commercially insured; a different verbal pathway for uninsured patients (direct them to the dispensing pharmacy's cash-pay program).
Route all prescriptions to Sterling Specialty Pharmacy: The PAP only works at the designated dispensing pharmacy. If the prescription goes to a retail pharmacy, neither the cost reduction nor the access benefit will apply.
Document in the chart: Note that the patient received PAP enrollment information. This creates a record if pharmacy access issues arise at follow-up.
Savings Options for Medicare and Medicaid Patients
Patients on Medicare or Medicaid cannot use manufacturer copay cards due to federal anti-kickback provisions. For these patients, consider:
Checking Part D formulary: The generic (orphenadrine/aspirin/caffeine) may be covered at a lower tier than the brand. Generic availability is inconsistent, but worth checking.
Therapeutic alternatives: Cyclobenzaprine and methocarbamol are widely covered by Medicare Part D and Medicaid at very low or no copay. If access and cost are the primary concerns for a Medicare/Medicaid patient, these alternatives may be more practical.
Extra Help (Low Income Subsidy): Medicare Part D beneficiaries who qualify for Extra Help may have significantly reduced drug costs regardless of formulary tier.
Using medfinder to Support Patient Access
Even with the PAP in place, some patients face access barriers — pharmacies they can't identify, specialty pharmacy routing confusion, or geographic distance from dispensing locations. medfinder for providers helps your patients locate pharmacies that can fill their Norgesic or generic prescription without making dozens of phone calls. Patients submit their medication and location; medfinder contacts pharmacies on their behalf and texts back results. This is a valuable complement to the PAP for practices that prescribe Norgesic regularly.
Quick Reference: Norgesic Savings Summary for Providers
Commercially insured: $0 per fill via Galt copay card (up to $150 coverage) at designated dispensing pharmacy
Uninsured/underinsured: $30 / 60 tabs or $45 / 90 tabs with home delivery (max $60 regardless of quantity)
Medicare/Medicaid: PAP not applicable; check Part D generic coverage or consider covered alternatives
Starter samples: Available to providers through norgesic.com for qualified patients
Key action: Route prescriptions to Sterling Specialty Pharmacy; hand PAP card at visit; educate staff on specialty pharmacy routing
Frequently Asked Questions
Visit norgesic.com/resources to download the patient copay assistance card and provider information sheet. Commercially insured patients who are 18 or older with a valid prescription can use the copay card to pay $0 per fill (up to $150 coverage) when the prescription is filled at Galt's designated dispensing pharmacy.
No. Federal regulations prohibit the use of manufacturer copay assistance cards for prescriptions covered by Medicare, Medicaid, TRICARE, or other federal/state programs. For these patients, consider checking Part D generic formulary coverage or prescribing a covered alternative like cyclobenzaprine.
No. The PAP enrollment is handled through the dispensing pharmacy at the time the prescription is filled. Your role is to (1) hand the patient the copay card at the visit, and (2) route the prescription to Sterling Specialty Pharmacy or the Galt dispensing network.
Uninsured or underinsured patients can access Norgesic through Galt's cash-pay program: $30 for 60 tablets or $45 for 90 tablets with home delivery, capped at $60 per prescription regardless of quantity. This is available through the Galt Central Fulfillment Pharmacy.
Yes. Providers can request starter pack samples through norgesic.com. Galt ships sample packs to registered practices for use with qualified patients. This allows patients to try the medication before committing to a full prescription.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Norgesic also looked for:
More about Norgesic
32,900 have already found their meds with Medfinder.
Start your search today.





